BlackRock, Inc. - 30 Sep 2025 SCHEDULE 13G/A Report for 4D Molecular Therapeutics, Inc. Common Stock (FDMT)

Filing Manager: BlackRock, Inc.
Reporting Manager: BlackRock, Inc.
Security: 4D Molecular Therapeutics, Inc. Common Stock
Symbol: FDMT
Shares outstanding: 46,402,970 shares
Disclosed Ownership: 3,062,596 shares
Ownership: 6.6%
Form type: SCHEDULE 13G/A
Filing time: 17 Oct 2025, 18:13:43 UTC
Date of event: 30 Sep 2025
Previous filing: 17 Apr 2025
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
BlackRock, Inc.	6.6%	3,062,596	2,988,740	0	Spencer Fleming	Managing Director